Literature DB >> 6588343

Gingival hyperplasia associated with nifedipine therapy. Report of a case.

D Lederman, H Lumerman, S Reuben, P D Freedman.   

Abstract

A case of gingival hyperplasia associated with the administration of nifedipine is reported. Clinically and histologically, the tissue resembled that seen in hyperplasia induced by phenytoin (Dilantin). We believe this to be the first reported case of gingival hyperplasia associated with this drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6588343     DOI: 10.1016/0030-4220(84)90283-4

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  18 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  Gingival enlargement induced by drugs.

Authors:  L Brunet; J Miranda; M Farré; L Berini; C Mendieta
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 3.  Drugs, medications and periodontal disease.

Authors:  P A Heasman; F J Hughes
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

Review 4.  Aspects on the benefit-risk balance of felodipine in hypertension.

Authors:  D Elmfeldt; S Westerling
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Drug-induced atypical hyperplasia enveloping salivary gland malignancy.

Authors:  Anjali Narwal; Virender Singh; Shashi Bala
Journal:  J Indian Soc Periodontol       Date:  2017 Sep-Oct

Review 6.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

7.  Nifedipine aggravates cyclosporine A-induced gingival hyperplasia.

Authors:  A Bökenkamp; B Bohnhorst; C Beier; N Albers; G Offner; J Brodehl
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

Review 8.  Calcium channel blocker-induced gingival enlargement.

Authors:  R Livada; J Shiloah
Journal:  J Hum Hypertens       Date:  2013-06-06       Impact factor: 3.012

9.  Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in the gingiva: A case report.

Authors:  Qing Yu; Wen-Xia Wang
Journal:  World J Clin Cases       Date:  2020-02-06       Impact factor: 1.337

10.  Calcium channel blocker induced gingival overgrowth.

Authors:  L Michael Prisant; Wayne Herman
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jul-Aug       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.